Article
Association of CYP2B6 Single-Nucleotide Polymorphisms Altering Efavirenz Metabolism With Hepatitis C Virus (HCV) Treatment Relapse Among Human Immunodeficiency Virus/HCV-Coinfected African Americans Receiving Ledipasvir/Sofosbuvir in the ION-4 Trial.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America - 1 Jun 2018
Kleinstein Sarah E, Shea Patrick R, Stamm Luisa M, Sulkowski Mark, Goldstein David B, Naggie Susanna
Abstract excerpt
In the ION-4 trial, hepatitis C virus relapse was rare, occurring only in African American patients, 80% receiving efavirenz for human immunodeficiency virus infection. We observed no indication that CYP2B6 polymorphisms associated with increased plasma efavirenz exposure explained the relapses.
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.